A Prescription Drug User Fee Act (PDUFA) target action date for apitegromab has been set for Sept. 22, 2025.

People can treat muscle atrophy by making lifestyle changes, trying physical therapy, or undergoing surgery. In this article, we look at some other causes, symptoms, and treatments of muscle atrophy.

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

In an interview, Scholar Rock's chief medical officer talks about benefits seen in clinical trials of its muscle-targeted SMA ...

The classification of spinal muscular atrophy (SMA) subtypes ... because even though we have treatment, muscles do not get stronger on their own. Rehabilitation and treatment together have ...

A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and ...

Innovator drug price is Rs 22-72 lakh per year; Analysts forecast Natco to price generic drug at Rs 3,000 per year ...

It occurs due to genetic changes and results in degeneration of the lower motor neurons, causing muscle weakness, muscle atrophy ... for people to receive prompt treatment to manage their symptoms.

Until recently, treatments for vulvovaginal atrophy were limited to often insufficient or inappropriate oral estrogen therapies and over-the-counter lubricants and moisturizers. Currently ...

Spinal muscular atrophy type 1 is a genetic disorder that typically appears within the first six months of life, causing severe muscle weakness and hypotonia. Babies with SMA often struggle to meet ...